BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 23861742)

  • 21. Merozoite surface protein 4/5 provides protection against lethal challenge with a heterologous malaria parasite strain.
    Goschnick MW; Black CG; Kedzierski L; Holder AA; Coppel RL
    Infect Immun; 2004 Oct; 72(10):5840-9. PubMed ID: 15385485
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Listeria monocytogenes inoculation protects mice against blood-stage Plasmodium yoelii infection.
    Qi Z; Han X; Zhang Y; Wang J; Cao YM
    Tohoku J Exp Med; 2013 Feb; 229(2):87-96. PubMed ID: 23303295
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
    Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
    Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Complete protective immunity induced in mice by immunization with the 19-kilodalton carboxyl-terminal fragment of the merozoite surface protein-1 (MSP1[19]) of Plasmodium yoelii expressed in Saccharomyces cerevisiae: correlation of protection with antigen-specific antibody titer, but not with effector CD4+ T cells.
    Hirunpetcharat C; Tian JH; Kaslow DC; van Rooijen N; Kumar S; Berzofsky JA; Miller LH; Good MF
    J Immunol; 1997 Oct; 159(7):3400-11. PubMed ID: 9317139
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Mycobacterium bovis BCG immunization induces protective immunity against nine different Mycobacterium tuberculosis strains in mice.
    Jeon BY; Derrick SC; Lim J; Kolibab K; Dheenadhayalan V; Yang AL; Kreiswirth B; Morris SL
    Infect Immun; 2008 Nov; 76(11):5173-80. PubMed ID: 18710860
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD47 regulates the phagocytic clearance and replication of the Plasmodium yoelii malaria parasite.
    Banerjee R; Khandelwal S; Kozakai Y; Sahu B; Kumar S
    Proc Natl Acad Sci U S A; 2015 Mar; 112(10):3062-7. PubMed ID: 25713361
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Parasitostatic effect of maslinic acid. II. Survival increase and immune protection in lethal Plasmodium yoelii-infected mice.
    Moneriz C; Marín-García P; Bautista JM; Diez A; Puyet A
    Malar J; 2011 Apr; 10():103. PubMed ID: 21518429
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Induction of ssDNA-binding autoantibody secreting B cell immunity during murine malaria infection is a critical part of the protective immune responses.
    Mannoor K; Li C; Inafuku M; Taniguchi T; Abo T; Sato Y; Watanabe H
    Immunobiology; 2013 Jan; 218(1):10-20. PubMed ID: 22361243
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Production of interleukin 10 during malaria caused by lethal and nonlethal variants of Plasmodium yoelii yoelii.
    Kobayashi F; Morii T; Matsui T; Fujino T; Watanabe Y; Weidanz WP; Tsuji M
    Parasitol Res; 1996; 82(5):385-91. PubMed ID: 8738275
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lactoferrin enhances efficacy of the BCG vaccine: comparison between two inbred mice strains (C57BL/6 and BALB/c).
    Hwang SA; Arora R; Kruzel ML; Actor JK
    Tuberculosis (Edinb); 2009 Dec; 89 Suppl 1():S49-54. PubMed ID: 20006305
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Involvement of CD8+ T cells in protective immunity against murine blood-stage infection with Plasmodium yoelii 17XL strain.
    Imai T; Shen J; Chou B; Duan X; Tu L; Tetsutani K; Moriya C; Ishida H; Hamano S; Shimokawa C; Hisaeda H; Himeno K
    Eur J Immunol; 2010 Apr; 40(4):1053-61. PubMed ID: 20101613
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
    Tian JH; Kumar S; Kaslow DC; Miller LH
    Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
    [TBL] [Abstract][Full Text] [Related]  

  • 33. BCG-mediated protection against M. tuberculosis is sustained post-malaria infection independent of parasite virulence.
    Tangie E; Walters A; Hsu NJ; Fisher M; Magez S; Jacobs M; Keeton R
    Immunology; 2022 Feb; 165(2):219-233. PubMed ID: 34775598
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Whole-Killed Blood-Stage Vaccine-Induced Immunity Suppresses the Development of Malaria Parasites in Mosquitoes.
    Zhu F; Liu T; Zhao C; Lu X; Zhang J; Xu W
    J Immunol; 2017 Jan; 198(1):300-307. PubMed ID: 27903741
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization of mice with Plasmodium TCTP delays establishment of Plasmodium infection.
    Taylor KJ; Van TT; MacDonald SM; Meshnick SR; Fernley RT; Macreadie IG; Smooker PM
    Parasite Immunol; 2015 Jan; 37(1):23-31. PubMed ID: 25376500
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunogenicity and protective efficacy of a Plasmodium yoelii Hsp60 DNA vaccine in BALB/c mice.
    Sanchez GI; Sedegah M; Rogers WO; Jones TR; Sacci J; Witney A; Carucci DJ; Kumar N; Hoffman SL
    Infect Immun; 2001 Jun; 69(6):3897-905. PubMed ID: 11349057
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Outcomes of controlled human malaria infection after BCG vaccination.
    Walk J; de Bree LCJ; Graumans W; Stoter R; van Gemert GJ; van de Vegte-Bolmer M; Teelen K; Hermsen CC; Arts RJW; Behet MC; Keramati F; Moorlag SJCFM; Yang ASP; van Crevel R; Aaby P; de Mast Q; van der Ven AJAM; Stabell Benn C; Netea MG; Sauerwein RW
    Nat Commun; 2019 Feb; 10(1):874. PubMed ID: 30787276
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Bacillus Calmette-Guérin-inoculation at different time points influences the outcome of C57BL/6 mice infected with Plasmodium chabaudi chabaudi AS.
    Cao DH; Wang JC; Liu J; Du YT; Cui LW; Cao YM
    Folia Parasitol (Praha); 2016 Apr; 63():. PubMed ID: 27188912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
    Aly AS; Downie MJ; Mamoun CB; Kappe SH
    Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Controlled Infection Immunization Using Delayed Death Drug Treatment Elicits Protective Immune Responses to Blood-Stage Malaria Parasites.
    Low LM; Ssemaganda A; Liu XQ; Ho MF; Ozberk V; Fink J; Sundac L; Alcorn K; Morrison A; O'Callaghan K; Gerrard J; Stanisic DI; Good MF
    Infect Immun; 2019 Jan; 87(1):. PubMed ID: 30323025
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.